122 related articles for article (PubMed ID: 2447403)
1. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Simon G; Wittig VJ
J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
3. Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
Van Den Heuvel AF; van der Ent M; van Veldhuisen DJ; Kruijssen DA; Bartels GL; Remme WJ
J Cardiovasc Pharmacol; 1998 Apr; 31(4):506-12. PubMed ID: 9554797
[TBL] [Abstract][Full Text] [Related]
4. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
6. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
Smith SA; Littler WA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
[TBL] [Abstract][Full Text] [Related]
7. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
Lefebvre RA; Bogaert MG; Duprez D
Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
10. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
Ruddy MC; Bialy GB; Kostis JB
Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
[TBL] [Abstract][Full Text] [Related]
13. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats.
Ozawa H; Matsubara T; Chen CS
Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631
[TBL] [Abstract][Full Text] [Related]
16. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
17. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
[TBL] [Abstract][Full Text] [Related]
18. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.
Taverner D; Mackay IG; Craig K; Watson ML
Br J Clin Pharmacol; 1991 Sep; 32(3):387-91. PubMed ID: 1685667
[TBL] [Abstract][Full Text] [Related]
19. The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
Lees KR; Curzio J; Farish E; Borland WW; Rubin PC
Eur J Clin Pharmacol; 1987; 33(4):415-7. PubMed ID: 2894994
[TBL] [Abstract][Full Text] [Related]
20. Pindolol increases plasma norepinephrine concentration by stimulation of beta 2-adrenoceptors in conscious spontaneously hypertensive rats.
Keeton TK
J Cardiovasc Pharmacol; 1990 Sep; 16(3):354-9. PubMed ID: 1700204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
